Enrolling by invitationPhase 4NCT06040255

Focal Cerebral Arteriopathy Steroid Trial

Studying Pediatric arterial ischemic stroke

Last synced from ClinicalTrials.gov May 17, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of California, San Francisco
Principal Investigator: Heather J Fullerton, MD, MAS
University of California, San Francisco
Intervention: methylprednisolone, prednisolone, prednisone(drug)
Enrollment: 80 enrolled
Eligibility: 1-18 years · All sexes
Timeline: 2023 – 2030

Study locations (1)

University of California San Francisco, San Francisco, California, United States

Collaborators

University of Cincinnati · Medical University of South Carolina · M.D. Anderson Cancer Center · University of Colorado, Denver · University of Iowa · National Institute of Neurological Disorders and Stroke (NINDS) · American Heart Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06040255 on ClinicalTrials.gov

Other trials for Pediatric arterial ischemic stroke

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00084292
Database for Stroke in Infants and Children: the International Pediatric Stroke Study
The Hospital for Sick Children

See all trials for Pediatric arterial ischemic stroke →

← Back to all trials